Figure 1.

Overall survival (OS), event-free survival (EFS, and probability of continued remission. MAP/IND vs SOC (A-C) and for MAP/IND (reasons other than cell viability 70% to 79%) vs combined SOC and MAP/IND with cell viability 70% to 79% (D-F). OS is defined by time of CAR infusion to the date of death, with data censored at the time of last follow-up. EFS is defined as time of CAR infusion to the earliest event, with events defined as non-response, relapse or death, with data censored at the time of last follow up and hematopoietic stem cell transplantation (HSCT). Duration of remission includes patients achieving CR at day 28, with events defined as relapse and death and data censored for time of last follow up and HSCT.